Business
This company has entered a trading halt, is it about to announce FDA approval?
Image source: Getty Images
Orthocell Ltd (ASX: OCC) is an Australian medical technology company focused on developing and commercialising innovative regenerative medicine treatments.
Over the last 12 months its share price has skyrocketed, up more than 260% in that span.
For context, S&P/ASX…
Continue Reading
-
Business23 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News20 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
General7 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A
-
Business20 hours ago1 ASX dividend stock down 43% I’d buy right now